Wockhardt Update by Epic Research

Wockhardt has received Qualified Infectious Disease Product (QIDP) status from the US health regulator — US Food and Drug Administration (USFDA) — for two of its anti-infective drugs WCK 771 and WCK 2349. This is the first instance of an Indian pharmaceutical company receiving QIDP status.



Real Time News & Trading Trends Keep Liking #EpicResearch




Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+



For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH

Posted in: Indian Market Tips